Incidence, mortality, and cost trends in nonventilator hospital-acquired pneumonia in medicaid beneficiaries, 2015-2019

Karen K. Giuliano, Dian Baker, Madhuli Thakkar-Samtani, Michael Glick, Marcos I. Restrepo, Frank A. Scannapieco, Lisa J. Heaton, Julie Frantsve-Hawley

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Nonventilator hospital-acquired pneumonia is associated with substantial morbidity, mortality, and costs during an episode of acute care. We examined NVHAP incidence, mortality, and costs of Medicaid beneficiaries over a 5-year period (2015-2019). Overall NVHAP incidence was 2.63 per 1,000 patient days, and mortality was 7.76%, with an excess cost per NVHAP case of $20,189.

Original languageEnglish (US)
Pages (from-to)227-230
Number of pages4
JournalAmerican Journal of Infection Control
Volume51
Issue number2
DOIs
StatePublished - Feb 2023
Externally publishedYes

Keywords

  • Epidemiology
  • NVHAP
  • Non-ventilator Hospital-acquired pneumonia
  • Nosocomial infection

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases
  • Health Policy
  • Epidemiology

Fingerprint

Dive into the research topics of 'Incidence, mortality, and cost trends in nonventilator hospital-acquired pneumonia in medicaid beneficiaries, 2015-2019'. Together they form a unique fingerprint.

Cite this